Basingstoke, RG21 8SR,
United Kingdom
Crescent Pharma Ltd Technographics
Crescent Pharma Ltd Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Crescent Pharma Ltd and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 102 Crescent Pharma Ltd employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Crescent Pharma Ltd has purchased the following applications: Sage Business Cloud X3 (ex Sage ERP X3) for ERP Financial in 2018, Microsoft 365 for Collaboration in 2019, Exclaimer Cloud Signatures for Office 365 for Digital Signing in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Crescent Pharma Ltd is running and its propensity to invest more and deepen its relationship with Sage , Microsoft , Exclaimer or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Crescent Pharma Ltd revenues, which have grown to $68.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Crescent Pharma Ltd intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Crescent Pharma Ltd Tech Stack and Enterprise Applications
Crescent Pharma Ltd ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Sage | Sage 200 | Sage Business Cloud X3 (ex Sage ERP X3) | ERP Financial | ERP | Mysoft | 2018 | 2018 |
In 2018 Crescent Pharma Ltd implemented Sage Business Cloud X3 (ex Sage ERP X3) under a Mysoft engagement to replace Sage 200 as the company outgrew its previous system and faced greater manufacturing and compliance complexity. The deployment targeted multi-site management across headquarters in Overton and multiple manufacturing and distribution sites in the United Kingdom, reflecting Crescent Pharma’s combined licensed and over the counter pharmaceutical production profile, and situates the project squarely in the ERP Financial category.
The implementation configured core Sage Business Cloud X3 capabilities for manufacturing operations, inventory and distribution control, quality control workflows, and enhanced financial control and ledgers to support regulatory traceability and product governance. The project emphasized the depth of data capture and structured quality control functionality typical of ERP Financial solutions, and the modern browser based interface reduced the need for individual user installs while enabling centralized access and administration.
Mysoft executed the implementation leveraging prior pharma experience with customers such as Atnahs Pharma and Waymade PLC, providing industry-aligned configuration and functional validation with Crescent’s Quality Assurance team. The solution was designed to integrate with Crescent’s existing systems as required, delivering a centralized Sage X3 application layer that supports multi-site operations and distribution processes without necessitating per workstation installs.
Governance and rollout were driven by Crescent’s operational and quality stakeholders in collaboration with Mysoft, with partner selection motivated by industry knowledge and referenceability. The organization selected Sage Business Cloud X3 to reduce time and costs, minimise mistakes, and provide a scalable base for future growth, outcomes that were central to the business case for the ERP Financial deployment.
|
Crescent Pharma Ltd Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2019 | 2019 |
In 2019, Crescent Pharma Ltd deployed Microsoft 365 as its Collaboration platform. The deployment covered the 102-employee United Kingdom life sciences company and is referenced on the company website.
Microsoft 365 was configured to provide core collaboration capabilities including Exchange Online email and calendaring, SharePoint document management and intranet, Microsoft Teams for meetings and chat, OneDrive for file synchronization, and the Office productivity suite for desktop and web authoring. Configuration patterns align with collaboration workflows such as coauthoring, version control, meeting orchestration, and centralized content libraries.
Operational coverage focused on corporate collaboration across commercial and scientific teams, supported by tenant-level administration, role-based access controls, and policy-driven content governance to manage regulated documentation. The implementation emphasizes cloud-hosted collaboration services and centralized identity and access controls rather than on-premise infrastructure.
|
Crescent Pharma Ltd Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Exclaimer | Legacy | Exclaimer Cloud Signatures for Office 365 | Digital Signing | Content Management | n/a | 2019 | 2019 |
In 2019, Crescent Pharma Ltd deployed Exclaimer Cloud Signatures for Office 365. The implementation uses the cloud hosted Exclaimer service integrated with Office 365 mail flow to centralize signature management across the organization, reflecting the Digital Signing application category. The deployment is referenced on Crescent Pharma Ltd's public website.
Configuration emphasized centralized signature templates, rule based signature assignment using Office 365 user attributes, and delegated administrative controls to separate marketing and IT responsibilities. Operational scope covered corporate communications, marketing, and IT functions responsible for branding, message consistency, and directory synchronization. The architecture reflects a SaaS provisioning model with Exclaimer Cloud managing signature rendering while Office 365 handles mailbox routing and directory integration.
|
Crescent Pharma Ltd eCommerce
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
eCommerce | eCommerce |
|
2021 | 2021 |
|
Crescent Pharma Ltd CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Marketing Automation | CRM |
|
2017 | 2017 |
|
Crescent Pharma Ltd IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
Crescent Pharma Ltd CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Crescent Pharma Ltd
Apps Being Evaluated by Crescent Pharma Ltd Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||